Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$17.11 USD
-0.10 (-0.58%)
Updated May 14, 2024 04:00 PM ET
After-Market: $17.10 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -1.04 |
EPS Last Quarter | -0.05 |
Last EPS Surprise | 94.85% |
ABR | 1.20 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.02 |
Next Year | -3.64 |
EPS (TTM) | -3.11 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 110.38M | 27.90M | 239.87M | 135.69M |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 276.15M | 30.00M | 484.49M | 202.00M |
Low Estimate | 25.00M | 25.00M | 100.00M | 100.00M |
Year ago Sales | 29.00M | 32.00M | 117.00M | 239.87M |
Year over Year Growth Est. | 280.63% | -12.81% | 105.02% | -43.43% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.04 | -0.99 | -3.02 | -3.64 |
# of Estimates | 3 | 3 | 6 | 5 |
Most Recent Consensus | -0.88 | -0.70 | -2.35 | -3.46 |
High Estimate | -0.88 | -0.70 | -0.31 | -2.41 |
Low Estimate | -1.26 | -1.29 | -4.92 | -4.68 |
Year ago EPS | -1.04 | -0.94 | -4.15 | -3.02 |
Year over Year Growth Est. | 0.00% | -5.32% | 27.23% | -20.52% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 2 | 2 | 3 |
Up Last 30 Days | 0 | 2 | 2 | 3 |
Up Last 60 Days | 0 | 2 | 2 | 3 |
Down Last 7 Days | 2 | 0 | 2 | 0 |
Down Last 30 Days | 2 | 0 | 2 | 0 |
Down Last 60 Days | 2 | 0 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.04 | -0.99 | -3.02 | -3.64 |
7 Days Ago | 0.08 | -1.04 | -3.21 | -4.07 |
30 Days Ago | 0.08 | -1.04 | -3.21 | -4.07 |
60 Days Ago | 0.75 | -0.91 | -2.85 | -3.59 |
90 Days Ago | NA | NA | -2.80 | -3.89 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.04 | -0.99 | -3.00 | -3.95 |
Zacks Consensus Estimate | -1.04 | -0.99 | -3.02 | -3.64 |
Earnings ESP | 0.00% | 0.00% | 0.54% | -8.44% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.05 | -1.08 | -0.94 | -1.04 | NA |
Estimate | -0.97 | -1.09 | -1.12 | -1.00 | NA |
Difference | 0.92 | 0.01 | 0.18 | -0.04 | 0.27 |
Surprise | 94.85% | 0.92% | 16.07% | -4.00% | 26.96% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more